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A B S T R A C T
Background
Total thyroidectomy (TT) and subtotal thyroidectomy (ST) are worldwide treatment options for multinodular non-toxic goitre in
adults. Near TT, defined as a postoperative thyroid remnant less than 1 mL, is supposed to be a similarly effective but safer option than
TT. ST has been shown to be marginally safer than TT, but it may leave an undetected thyroid cancer in place.
Objectives
The objective was to assess the effects of total or near-total thyroidectomy compared to subtotal thyroidectomy for multinodular non-
toxic goitre.
Search methods
We searched the Cochrane Library, MEDLINE, PubMed, EMBASE, as well as the ICTRP Search Portal and ClinicalTrials.gov. The
date of the last search was 18 June 2015 for all databases. No language restrictions were applied.
Selection criteria
Two review authors independently scanned the abstract, title or both sections of every record retrieved to identify randomised controlled
trials (RCTs) on thyroidectomy for multinodular non-toxic goitre for further assessment.
Data collection and analysis
Two review authors independently extracted data, assessed studies for risk of bias and evaluated overall study quality utilising the
GRADE instrument. We calculated the odds ratio (OR) and corresponding 95% confidence interval (CI) for dichotomous outcomes.
A random-effects model was used for pooling data.
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Main results
We examined 1430 records, scrutinized 14 full-text publications and included four RCTs. Altogether 1305 participants entered the four
trials, 543 participants were randomised to TT and 762 participants to ST. A total of 98% and 97% of participants finished the trials
in the TT and ST groups, respectively. Two trials had a duration of follow-up between 12 and 39 months and two trials a follow-up
of 5 and 10 years, respectively. Risk of bias across studies was mainly unknown for selection, performance and detection bias. Attrition
bias was generally low and reporting bias high for some outcomes. In the short-term postoperative period no deaths were reported for
both TT and ST groups. However, longer-term data on all-cause mortality were not reported (1284 participants; 4 trials; moderate
quality evidence). Goiter recurrence was lower in the TT group compared to ST. Goiters recurred in 0.2% (1/425) of the TT group
compared to 8.4% (53/632) of the ST group (OR 0.05 (95% CI 0.01 to 0.21); P < 0.0001; 1057 participants; 3 trials; moderate quality
evidence). Re-intervention due to goitre recurrence was lower in the TT group compared to ST. Re-intervention was necessary in 0.5%
(1/191) of TT patients compared to 0.8% (3/379)of ST patients (OR 0.66 (95% CI 0.07 to 6.38); P = 0.72; 570 participants; 1 trial;
low quality evidence). The incidence of permanent recurrent laryngeal nerve palsy was lower for ST compared with TT. Permanent
recurrent laryngeal nerve palsy occurred in 0.8% (6/741) of ST patients compared to 0.7% (4/543) of TT patients (OR 1.28, (95%
CI 0.38 to 4.36); P = 0.69; 1275 participants; 4 trials; low quality evidence). The incidence of permanent hypoparathyroidism was
lower for ST compared with TT. Permanent hypoparathyroidism occurred in 0.1% (1/741) of ST patients compared to 0.6% (3/543)
of TT patients (OR 3.09 (95% CI 0.45 to 21.36); P = 0.25; 1275 participants: 4 trials; low quality evidence). The incidence of thyroid
cancer was lower for ST compared with TT. Thyroid cancer occurred in 6.1% (41/669) of ST patients compared to 7.3% (34/465)of
TT patients (OR 1.32 (95% CI 0.81 to 2.15); P = 0.27; 1134 participants; 3 trials; low quality evidence). No data on health-related
quality of life or socioeconomic effects were reported in the included studies.
Authors’ conclusions
The body of evidence on TT compared with ST is limited. Goiter recurrence is reduced following TT. The effects on other key
outcomes such as re-interventions due to goitre recurrence, adverse events and thyroid cancer incidence are uncertain. New long-term
RCTs with additional data such as surgeons level of experience, treatment volume of surgical centres and details on techniques used are
needed.
P L A I N L A N G U A G E S U M M A R Y
Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Review question
What are the effects of total or near-total thyroidectomy compared with subtotal thyroidectomy for multinodular non-toxic goitre in
adults?
Background
Multinodular goitre refers to a generalised enlarged thyroid gland with recognisable nodules within it. The thyroid gland consists of
two connected lobes. People affected by goitre often present with a non-symmetrical enlargement of the thyroid gland with a visible
swelling in the anterior aspect of the neck. One or more nodules can be recognised. The most frequent cause of multinodular goitre is
iodine deficiency. Non-toxic goitre means that the nodules do not secret thyroid hormones in an uncontrolled way. Total thyroidectomy
is an operation that involves the surgical removal of the whole thyroid gland. Near-total thyroidectomy is an operation that involves
the surgical removal of both thyroid lobes except for a small amount of thyroid tissue (on one or both sides less than 1.0 mL). Subtotal
thyroidectomy leaves 3 g to 5 g on the less affected side of the thyroid gland.
After thyroidectomy one of the most important complications is recurrent nerve palsy because this nerve might be traumatised during
the surgery. A wide spectrum of complications to the voice, swallowing mechanisms, or both, can occur. A temporary or permanent
voice change can result. If the goitre reappears (goitre recurrence) some time after thyroidectomy, another surgical intervention might
be necessary. This surgery is more complicated than the initial surgery because of scar tissue making it difficult to identify nerves and
other important tissues. There is also the possibility that subtotal thyroidectomy, which is thought to be somewhat safer than total
thyroidectomy, may leave an undetected thyroid cancer in place.
Study characteristics
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We included four randomised controlled trials with a total of 1305 participants. A total of 543 participants were randomised to total
or near-total thyroidectomy and 762 participants to subtotal thyroidectomy. Two trials had a duration of follow-up between 12 and
39 months and two trials a follow-up of 5 and 10 years, respectively. Most participants were women and the average age was around
50 years.
Key results
In the short-termperiod after surgery no deaths were reported for both total thyroidectomy and subtotal thyroidectomy groups, however
longer-term data on all-cause mortality were not reported. Goitre recurrence was lower for total thyroidectomy compared to subtotal
thyroidectomy: the risk for goitre recurrence was 84 per 1000 trial participants for subtotal thyroidectomy and 5 per 1000 participants
(with a possible range of 1 to 19) for total thyroidectomy. There was no clear benefit or harm of either surgical technique for re-
operations because of goitre recurrence, side effects like permanent recurrent laryngeal nerve palsy or development of thyroid cancer.
No data on health-related quality of life or socioeconomic effects were reported in the included trials.
Quality of the evidence
The overall quality was low to moderate, mainly because of the small number of studies and participants as well as low rates of events
which makes distinction between harms and benefits of the two surgical techniques difficult.
Currentness of evidence
This evidence is up to date as of June 2015.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Total or near-total thyroidectomy compared with subtotal thyroidectomy for multinodular non-toxic goitre in adults
Patient: adults with multinodular non-toxic goitre
Settings: tertiary referral centre
Intervention: (near) total thyroidectomy
Comparison: subtotal thyroidectomy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Subtotal thyroidectomy (Near)total thyroidec-
tomy
All-cause mortality
Follow-up: 1 to 10 years
See comment See comment See comment 1284 (4) a) ⊕⊕⊕©
moderatea
No postoperative hospital
deaths or deaths within
the first 30 days occurred
after total or subtotal thy-
roidectomy
a)Goitre recurrence
b)Re-intervention due to
goitre recurrence
Follow-up: a) 3 to 10
years, b) 5 years
a)84 per 1000
b) 8 per 1000
a) 5 per 1000 (1 to 19)
b) 5 per 1000 (1 to 48)
a) OR 0.05 (0.01 to 0.21)
b) OR 0.66 (0.07 to 6.38)
a) 1057 (3)
b) 570 (1)
a) ⊕⊕⊕©
moderateb
b) ⊕⊕©©
lowc
-
Adverse events:
a) Permanent recurrent
laryngeal nerve palsy
b) Permanent
hypoparathyroidism
Follow-up: a) 1 to 10
years, b) 1 to 10 years
a) 8 per 1000
b) 1 per 1000
a) 10 per 1000 (3 to 34)
b) 4 per 1000 (1 to 28)
a) OR 1.28 (0.38 to 4.36)
b) OR 3.09 (0.45 to 21.
36)
a) 1275 (4)
b) 1275 (4)
a)
⊕⊕©©
lowd
b)
⊕⊕©©
lowd
-
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Thyroid cancer inci-
dence
Follow-up: 1 to 5 years
61 per 1000 79 per 1000 (50 to 123) OR 1.32 (0.81 to 2.15) 1134 (3) ⊕⊕©©
lowd
-
Health-related quality of
life
See comment See comment See comment See comment See comment Outcome not investigated
Socioeconomic effects See comment See comment See comment See comment See comment Outcome not investigated
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; OR: odds ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
Assumed risk: mean control group risk across studies
aDowngraded by one level because of high risk of outcome reporting bias (no trial investigated all-cause mortality over longer periods of
follow-up)
bDowngraded by one level because of small number of events and unknown risk of detection bias
cDowngraded by two levels because of high risk of outcome reporting bias (3 of 4 trials did not report re-interventions due to goitre
recurrence), imprecision and one study only with small number of participants and low event rates
dDowngraded by two levels because of imprecision and low event rates
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B A C K G R O U N D
Multinodular non-toxic goitre is the most common endocrine
condition, consisting of a nodular overgrowth of the thyroid
gland which is not associated with either malignancy or hyperthy-
roidism. This can be treated conservatively, but in the vast ma-
jority of cases it needs surgical intervention. The indications for
surgical treatment of multinodular non-toxic goitre are:
• large size goitre or increase in size despite treatment with
thyroid-stimulating hormone (TSH);
• compression symptoms (i.e. dyspnoea or dysphagia);
• suspected or proven malignant changes; and
• cosmetic reasons.
The optimal surgical procedure for multinodular non-toxic goitre
is still debated. Surgeons may decide to remove the entire thyroid
gland in a single operation (total thyroidectomy) or to limit the re-
section to only part of the thyroid tissue (subtotal thyroidectomy),
in order to remove only the diseased part and thus minimise the
risk of recurrent nerve palsy and hypocalcaemia, which are more
frequently associated with total thyroidectomy. Total thyroidec-
tomy has the advantage of one-stage removal of incidental thyroid
cancer and a lower risk of developing recurrent goitre. In addition,
in total thyroidectomy there is no consensus on the safety and
cost-effectiveness of the use of the clamp and tie technique versus
the use of a diathermy (i.e. electrically induced heat) system for
vessel ligation and division (i.e. LigaSure or Ultracision) (Cirocchi
2010).
Developments in surgical technique including systematic identifi-
cation of recurrent laryngeal nerve palsy, and intraoperative neuro-
monitoring have led to a reduction in the incidence of recur-
rent nerve lesions andpost-surgical hypoparathyroidism (Donatini
2012).
Although this topic has been the subject of several studies (Foster
1978; Perzik 1976), the question of which of the two surgical pro-
cedures (i.e. total or subtotal thyroidectomy) should be performed
remains unanswered.
Description of the condition
The term multinodular goitre describes an enlarged, diffusely het-
erogeneous thyroid gland. Initial findings may include diffuse en-
largement, but asymmetrical nodularity of the mass often devel-
ops. Multinodular goitre refers to a generalised enlarged thyroid
gland with recognisable nodules within it. Patients affected by this
condition often present with a non-symmetrical enlargement of
the thyroid gland with a visible swelling in the anterior aspect of
the neck and a heterogeneously rough surface on palpation. One
or more nodules can be recognised. The most frequent cause of
multinodular goitre is iodine deficiency.
Description of the intervention
Total thyroidectomy is an operation that involves the surgical re-
moval of the whole thyroid gland, with the preservation of the
parathyroid glands. A small transverse incision is performed in the
inferior portion of the neck at the level of one of the natural creases,
2 to 3 cm above the sternal notch. The platysma is divided and
the skin flaps are elevated superiorly and inferiorly. The midline is
divided on avascular plane and the strap muscles are retracted lat-
erally and the thyroid is retracted medially. Using blunt dissection
the thyroid is dissected from the surrounding structures and then
a ligation of the inferior and superior pole vessels is performed.
The inferior laryngeal nerve is visualized and preserved as well as
parathyroids. Finally it is possible to perform the lobectomy. The
same technique is used for both lobes. After total thyroidectomy
patients usually take a prescribed oral synthetic thyroid hormone
to prevent hypothyroidism.
Near-total thyroidectomy is an operation that involves the surgical
removal of both lobes except for a small amount of thyroid tissue
(i.e. less than 1.0 mL) on one or both sides in the vicinity of the
recurrent laryngeal nerve entry point and the superior parathy-
roid gland. This operation follows the same technique as total thy-
roidectomy.
Subtotal thyroidectomy, including thyroid lobectomy and isthmu-
sectomy, is defined as a lobectomywith contralateral subtotal resec-
tion leaving 3 g to 5 g of normal remnant tissue on the less affected
side following the same technique as described above (Barczynski
2010). Thyroid hormonal release is maintained.
The Dunhill procedure consists of unilateral extracapsular total
thyroidectomy and contralateral subtotal thyroid lobe resection
leaving a thyroid stump of approximately 2 g of normal remnant
tissue.
Adverse effects of the interventions
The most frequent complications of total thyroidectomy and
subtotal thyroidectomy are transient or permanent hypocalcaemia
and recurrent nerve palsy. Hypocalcaemia is caused by the unin-
tentional excision of the parathyroid glands or by devascularization
of the parathyroid glands during the surgical manoeuvres. Rates
of postprocedural hypocalcaemia are approximately 5%, resolv-
ing in 80% of cases within approximately 12 months. Transient
or permanent recurrent nerve palsy occurs due to a traumatised
inferior laryngeal nerve. A wide spectrum of injuries to the voice,
swallowing mechanisms, or both, can occur because of the mixed
fibres containedwithin the nerve. A temporary or permanent voice
change can result, which can be extremely distressing to the pa-
tient. Recurrent nerve palsy, when unilateral, presents with a one-
sided paralysed vocal cord causing voice change. Bilateral nerve
palsy can seriously jeopardise the breathing mechanism and often
requires the establishment of surgical airways.
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The incidence of recurrent goitre after bilateral subtotal thyroidec-
tomy is elevated and varies between 1.2% at a maximum follow-
up of 55 months (Ozbas 2005), to 50% at a maximum follow-
up of 180 months (Ríos 2005). After a secondary intervention for
recurrent goitre, the incidence of nerve lesions and hypoparathy-
roidism is higher due to the difficulty in identifying, within scar
tissue, the inferior laryngeal nerves and the parathyroid glands
(Lefevre 2007).
How the intervention might work
Although total thyroidectomy allows a more easy follow-up of pa-
tients and avoids relapses of disease, a good proportion of sur-
geons prefer a more conservative intervention because multinodu-
lar nontoxic goitre is a benign disease. Thus the eventual compli-
cations of total thyroidectomymay not be justified and the conser-
vative approach may preserve endogenous thyroid function (Yang
2009). Sub-total thyroidectomy could avoid bilateral inferior la-
ryngeal nerve injury but some relapses of disease are possible over
time.
Why it is important to do this review
Agarwal 2008 performed a systematic review to evaluate total thy-
roidectomy as a surgical procedure for benignmultinodular goitre.
Total thyroidectomy appeared to be a safe option in the hands of
expert surgeons. Near-total thyroidectomywas shown to be a simi-
larly effective but safer option than total thyroidectomy. However,
although subtotal thyroidectomy was marginally safer than total
thyroidectomy, it may leave undetected thyroid cancers in place.
The review authors concluded that total thyroidectomy should be
the procedure of choice for the surgical management of benign
multinodular goitre (Agarwal 2008).
In their recent review on surgical treatment of endemic goitre
Dralle 2011 provide several arguments in support of the use of
total thyroidectomy as the treatment of choice:
• non-toxic goitres involve the entire gland;
• the development of sophisticated technologies has reduced
the intraoperative complications associated with total
thyroidectomy;
• in many cases (33%) patients receiving subtotal
thyroidectomy required completion because of detection of
incidental cancer;
• ultrasonography often reveals recurrent goitres post subtotal
thyroidectomies; and
• hormone replacement therapy is not expensive and is
generally well tolerated by patients.
However, Dralle 2011 points out several factors that need to be
considered when planning surgical treatment:
• the treatment of iodine insufficiency does not necessarily
reverse a nodular goitre and the behaviour of the nodules over
time is difficult to predict;
• to gain a high level of expertise surgeons need to ’super-
specialise’ which is often not sustainable worldwide; and
• hormone-replacement therapy is not viable everywhere in
the world.
Due to the high prevalence of multinodular non-toxic goitre, this
review aims to assess the effects of total versus subtotal thyroidec-
tomy. Although total thyroidectomy appears to be effective, safe
and convenient, clinical evidence supporting its use is still lacking.
O B J E C T I V E S
The primary objective was to assess the effects of total or near-total
thyroidectomy compared to subtotal thyroidectomy for multin-
odular non-toxic goitre.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs).
Types of participants
Adult (older than 18 years) participants with non-toxic multin-
odular goitre were considered for inclusion.
Diagnostic criteria
The diagnostic criteria were palpable thyroid nodules or multiple
solid or mixed lesions found on thyroid ultrasonography in an
euthyroid person.
Types of interventions
Intervention
• Total thyroidectomy
◦ Near-total thyroidectomy (unilateral or bilateral
thyroid remnant < 1.0 ml) was also regarded a total
thyroidectomy.
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Comparator
• Subtotal thyroidectomy (defined as the removal of part of
the gland, including thyroid lobectomy and isthmusectomy,
allowing maintenance of thyroid hormone release)
◦ Dunhill procedure (hemithyroidectomy plus subtotal
resection: unilateral thyroid remnant of 2 ml to 4 ml) is also
regarded a subtotal thyroidectomy.
Types of outcome measures
Primary outcomes
The primary outcomes include:
• All-cause mortality.
• Goitre recurrence and re-intervention due to goitre
recurrence.
• Adverse events.
Secondary outcomes
The secondary outcomes include:
• Thyroid cancer incidence.
• Health-related quality of life.
• Socioeconomic effects.
Method and timing of outcome measurement
• All-cause mortality: defined as any postoperative death and
measured 30 days postoperatively.
• Goitre recurrence: defined as the presence of nodular
involvement or an enlargement of the residual thyroid remnant.
• Re-intervention due to goitre recurrence: defined as
completion thyroidectomy for goitre recurrence.
• Adverse events included the following.
◦ Postoperative bleeding: defined as any postoperative
bleeding; minor bleeding defined as development of small,
superficial wound haematoma or bruising not requiring
intervention; or major bleeding defined as bleeding requiring
intervention. All bleeding outcomes were measured 30 days
postoperatively.
◦ Red cell transfusions: defined as any red cell transfused
after thyroidectomy and measured 30 days postoperatively.
◦ Permanent or transient recurrent laryngeal nerve
(RLN) palsy: transient was defined as RLN palsy during indirect
laryngoscopy performed by a throat specialist and measured 30
days postoperatively; permanent RLN palsy: was defined as a
vocal cord paresis for more than 12 months after the operation.
◦ Permanent or transient hypoparathyroidism: this
could be defined by hypocalcaemia (i.e. a total serum calcium
level less than 2.0 mmol/L in either asymptomatic or
symptomatic patients), perioral or fingertip paraesthesia or
numbness, tetany, or a newly positive Chvostek sign. These
outcomes were measured 12, 24, 48, and 72 hours
postoperatively. Persistent hypocalcaemia for more than six
months after the operation was regarded as permanent
hypoparathyroidism.
• Thyroid cancer incidence: defined as an unsuspected cancer
identified incidentally on pathologic examination of thyroid
tissue postoperatively.
• Health-related quality of life: measured by a validated
instrument such as the Medical Outcomes Study Short Form
Survey (SF-36) and measured 30 days postoperatively.
• Socioeconomic effects: defined as socioeconomic costs of
complications and measured at 6 and 12 months after surgery.
’Summary of findings’ table
We present a ’Summary of findings’ table’ reporting the following
outcomes based on priority:
• All-cause mortality.
• Goitre recurrence and re-intervention due to goitre
recurrence.
• Adverse events (especially recurrent laryngeal nerve injury).
• Thyroid cancer incidence.
• Health-related quality of life.
• Socioeconomic effects.
Search methods for identification of studies
Electronic searches
We searched the following sources from inception of each database
to the specified date:
• Cochrane Library (18 June 2015):
◦ Cochrane Central Register of Controlled Trials
(CENTRAL, issue 5, May 2015)
◦ Database of Abstracts of Reviews of Effects (DARE,
issue 2, April 2015)
◦ Health Technology Assessment (HTA, issue 2, April
2015)
• Ovid MEDLINE(R) In-Process & Other Non-Indexed
Citations and Ovid MEDLINE(R) (1946 to Present, 18 June
2015).
• PubMed (only subsets not available on Ovid, 18 June 2015)
• EMBASE (1974 to 2015 Week 24, 18 June 2015)
• ClinicalTrials.gov. (18 June 2015)
• World Health Organization (WHO) International Clinical
Trials Registry Platform (ICTRP) Search Protal (http://
apps.who.int/trialsearch/), which is a meta-register of trials with
links to several trial registers,
◦ Australian New Zealand Clinical Trials Registry (15
June 2015).
◦ Chinese Clinical Trial Registry (15 June 2015).
◦ ClinicalTrials.gov (15 June 2015).
◦ EU Clinical Trials Register (EU-CTR, 4 May 2015).
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◦ ISRCTN (15 June 2015).
◦ The Netherlands National Trial Register (15 June
2015).
◦ Brazilian Clinical Trials Registry (ReBec, 26 May
2015).
◦ Clinical Trials Registry - India (26 May 2015).
◦ Clinical Research Information Service - Republic of
Korea (26 May 2015).
◦ Cuban Public Registry of Clinical Trials (26 May
2015).
◦ German Clinical Trials Register (1 June 2015).
◦ Iranian Registry of Clinical Trials (26 May 2015).
◦ Japan Primary Registries Network (26 May 2015).
◦ Pan African Clinical Trial Registry (26 May 2015).
◦ Sri Lanka Clinical Trials Registry (1 June 2015).
◦ Thai Clinical Trials Register (TCTR, 26 May 2015).
Detailed search strategies are reported in Appendix 1. We utilized
a MEDLINE via Ovid SP email alert service for identification
of newly published studies using the search strategy detailed in
Appendix 1. If we identified new studies for inclusion we would
have evaluated these and incorporated the findings in our review
before submission of the final review draft (Beller 2013).
Searching other resources
We tried to identify other potentially eligible trials or ancillary
publications by searching the reference lists of included trials, sys-
tematic reviews, meta-analyses, review articles and health technol-
ogy assessment reports.
Data collection and analysis
Selection of studies
Two review authors (RC,GD) independently scanned the abstract,
title or both sections of every record retrieved to identify studies
for further assessment. A third party (AS) resolved any differences
in opinion. If resolving disagreement was not possible, we planned
to add the article to those ’awaiting assessment’ and would have
contacted study authors for clarification. We present a PRISMA
(i.e. preferred reporting items for systematic reviews and meta-
analyses) flow-chart to document study selection (Liberati 2009).
Data extraction and management
For the studies that fulfilled the inclusion criteria, two review au-
thors (RC, GDR) independently extracted key participant and in-
tervention characteristics.We report data on efficacy outcomes and
adverse events using standard data extraction templates supplied
by the Cochrane Metabolic and Endocrine Disorders (CMED)
Group. We resolved any disagreements by discussion, or if re-
quired, by consulting a third review author (ST). For full details see
Characteristics of included studies; additional Table 1; Appendix
2; Appendix 3; Appendix 4; Appendix 5; Appendix 6; Appendix
7; Appendix 8; Appendix 9; Appendix 10.
We provide information about potentially-relevant ongoing stud-
ies including trial identifier in the table Characteristics of ongoing
studies and in Appendix 5 ’Matrix of study endpoints (publication
and trial documents)’. We tried to find the protocol for each in-
cluded study, either in databases of ongoing trials, in publications
of study designs, or both, and report these data in Appendix 5.
We sent an email request to authors of included studies to enquire
whether they were willing to answer questions regarding their tri-
als. Appendix 11 reports the results of this survey. Thereafter if
required, we sought relevant missing information on the trial from
the study authors of the article.
Dealing with duplicate publications and companion papers
In the event of duplicate publications, companion documents or
multiple reports of a primary study, we maximised the yield of
information by collating all available data. In case of doubt the
publication reporting the longest follow-up associated with our
primary or secondary outcomes obtained priority.
Assessment of risk of bias in included studies
Two review authors (ST, RC) independently assessed the risk of
bias of each included study. We resolved disagreements by con-
sensus, or with consultation of a third party (MB).
We used Cochrane’s ’Risk of bias’ assessment tool (Higgins 2011a;
Higgins 2011b), and evaluated the following criteria.
• Random sequence generation (selection bias).
• Allocation concealment (selection bias).
• Blinding (performance bias and detection bias), separated
for blinding of participants and personnel and blinding of
outcome assessment.
• Incomplete outcome data (attrition bias).
• Selective reporting (reporting bias).
• Other potential sources of bias.
We judged the above ’Risk of bias’ criteria as either ’low’, ’high’,
or ’unclear’ risk and evaluated individual bias items as described
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011a). We present a risk of bias graph and a risk of bias
summary. We assessed the impact of individual bias domains on
study results at endpoint and study levels.
For blinding of participants and personnel (performance bias),
detection bias (blinding of outcome assessors) and attrition bias
(incomplete outcome data) we intended to evaluate risk of bias
separately for subjective and objective outcomes (Hróbjartsson
2013). We considered the implications of missing outcome data
from individual participants.
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We assessed outcome reporting bias by integrating the results of
the Appendix 5 ’Matrix of study endpoints (publication and trial
documents)’ with those of the Appendix 6 ’High risk of outcome
reporting bias according toORBITclassification’ (Kirkham 2010).
This analysis formed the basis for the judgement of selective re-
porting (reporting bias).
We defined the following outcomes as subjective outcomes.
• Adverse events.
• Health-related quality of life.
We defined the following outcomes as objective outcomes.
• All-cause mortality.
• Goitre recurrence and re-intervention due to goitre
recurrence.
• Thyroid cancer incidence.
• Socioeconomic effects.
Measures of treatment effect
We expressed dichotomous data as odds ratios (ORs) with 95%
confidence intervals (CIs). We expressed continuous data as mean
differences (MD) with 95% CIs.
Unit of analysis issues
We planned to take into account the level at which randomisation
occurred, such as cross-over trials, cluster-randomised trials and
multiple observations for the same outcome.
Dealing with missing data
If feasible, we obtained relevant missing data from trial authors.
We evaluated important numerical data such as the number of
screened, eligible, and randomised participants; as well as inten-
tion-to-treat (ITT), as-treated and per-protocol populations. We
investigated attrition rates including drop-outs, losses to follow-
up and withdrawals. We critically appraised issues of missing data
and imputation methods (e.g. last observation carried forward).
Where standard deviations for outcomes were not reported and
we did not receive information from study authors, we planned
to impute these values by assuming the standard deviation of the
missing outcome to be the average of the standard deviations from
those studies where this information was reported. We planned to
investigate the impact of imputation on pooled effect estimates by
means of sensitivity analysis.
Assessment of heterogeneity
We did not pool data for meta-analysis in the event of substantial
clinical, methodological or statistical heterogeneity. We assessed
heterogeneity by visual inspection of the forest plots and by calcu-
lating the Chi² test. In view of the low power of this test an α of
0.1 was considered to be statistically significant. We also examined
heterogeneity using the I² statistic, which quantifies inconsistency
across studies to assess the impact of heterogeneity on the meta-
analysis (Higgins 2002; Higgins 2003). An I² statistic of 75% or
more indicates a high degree of heterogeneity.
Had we found heterogeneity, we would have attempted to deter-
mine potential reasons for it by examining individual study and
subgroup characteristics.
We expected the following characteristics to introduce clinical het-
erogeneity.
• Age.
• Preoperative thyroid-stimulating hormone (TSH) levels.
• Preoperative thyroid volume (assessed by ultrasound).
• Surgeon’s experience.
Assessment of reporting biases
Because there were fewer than 10 studies investigating a particular
outcome, we did not construct a funnel plot to assess small-study
effects (Sterne 2011).
Data synthesis
Even if there was good evidence for homogeneous effects across
studies, we utilized a random-effects model because such models
are more appropriate in medical decision making contexts, espe-
cially when there are rare events (Ades 2005; DerSimonian 1986;
Fleiss 1991; Shuster 2007). We interpreted random-effects meta-
analyses with due consideration of the whole distribution of effects
(Higgins 2009). In addition, we performed statistical analyses ac-
cording to the statistical guidelines described in the latest version
of the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011c).
Quality of evidence
We assessed the overall quality of the body of evidence support-
ing each outcome using the ’Grading of Recommendations As-
sessment, Development and Evaluation (GRADE)’ criteria which
takes into account issues related to internal (e.g. risk of bias, in-
consistency, imprecision, and publication bias) and external va-
lidity (e.g. directness of results). Two review authors (ST, RC) in-
dependently rated the quality for each outcome. We reported a
summary of the GRADE analysis in a ’Summary of findings’ ta-
ble. This table provides key information about the best estimate
of the magnitude of the effect, in relative terms and absolute dif-
ferences, for each relevant comparison of alternative management
strategies, numbers of participants, and studies addressing each
important outcome and the rating of the overall confidence in
effect estimates for each outcome. We created the ’Summary of
findings’ table based on the methods described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011c).
We reported results for the outcomes described in the Types of
outcome measures section. If meta-analysis was not possible, we
reported results in a narrative ’Summary of findings’ table.
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Subgroup analysis and investigation of heterogeneity
We planned to carry out the following subgroup analyses with
investigation of interactions:
• Treatment volume: low volume (defined as less than 50
thyroid operations per year) versus high volume (defined as 50 or
more thyroid operations per year).
• Residents in general surgery versus surgeons.
• Participants aged less than 75 years versus 75 years or older.
• Participants with a body mass index less than 35 kg/m²
versus body mass index greater than 40 kg/m².
• Thyroidectomy with tie and clamp versus Ultracision or
Ligasure.
However, there were not enough data to carry out these analyses.
Sensitivity analysis
We intended to perform sensitivity analyses in order to explore the
influence of the following factors on effect size.
• Published studies.
• Taking into account risk of bias, as specified in the
’Assessment of risk of bias in included studies’ section.
• Very long or large studies to establish the extent to which
they dominate the results.
• Studies using the following filters: diagnostic criteria,
imputation, language of publication, source of funding (industry
versus other), or country.
However, there were too few studies to do so.
We also planned to test the robustness of the results by repeating
the analysis using different measures of effect size (RR, OR, etc.)
and different statistical models (fixed-effect and random-effects
models).
R E S U L T S
Description of studies
For a detailed description of studies, see the ’Characteristics of
included studies’, ’Characteristics of excluded studies, and ’Char-
acteristics of ongoing studies’ sections.
Results of the search
Our comprehensive literature searches identified a total of 1430
records. There were 1173 records after de-duplication. From these,
14 full-text papers were identified for further examination. We
excluded the other publications on the basis of titles or abstracts
because inclusion criteria were not met or because the studies
were not relevant to the review objectives. See Figure 1 for the
amended PRISMA study flow diagram. After screening the full-
text of the selected publications, four studies (four publications)
met the inclusion criteria. All studies were published in English.
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Figure 1. Study flow diagram.
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Included studies
A detailed description of the characteristics of the included studies
is presented elsewhere (see Characteristics of included studies and
appendices). The following is a succinct overview:
Source of data
Using the literature search strategy 1430 publications were identi-
fied: 504 in MEDLINE (via OVID), 57 in PubMed (subsets not
available on OVID), 106 in the Cochrane Library, 734 in EM-
BASE, 13 in the WHO ICTRP and 16 in ClinicalTrials.gov.
Comparisons
One study compared total to subtotal thyroidectomy (Pappalardo
1998). Two studies compared total or near-total thyroidectomy to
subtotal thyroidectomy (Giles 2004; Yang 2009), and one study
compared total thyroidectomy to the Dunhill procedure or subto-
tal thyroidectomy (Barczynski 2010).
Overview of study populations
A total of 1305 participants were included in the four trials, 543
participants were randomised to total or near-total thyroidectomy
and 762 to subtotal thyroidectomy. A total of 534 (98%) partic-
ipants finished the study in the total or near-total thyroidectomy
group compared to 741 (97%) participants in the subtotal thy-
roidectomy group. The individual sample size of randomised par-
ticipants ranged from 141 (Pappalardo 1998) to 600 (Barczynski
2010)
Study design
Studies were randomised controlled trials. All four trials utilized a
parallel group superiority design. One trial was multicentric (Yang
2009). In terms of blinding, none of the trials was double-blinded
for participants and personnel. No information about blinding
of outcome assessors was available. Studies were performed be-
tween the years 1975 and 2006. The median duration of follow-
up ranged from 3 to 14.5 years (Pappalardo 1998). No trials were
terminated early.
Settings
All studies were conducted in academic hospitals. No study was
performed in an outpatient setting.
Participants
The participating population consisted of the following: all tri-
als included participants from economically developed countries,
which recruited participants fromChina, Italy, Poland, Turkey and
the USA. Surgical procedures were most commonly performed
in women. The mean (standard deviation) age of participants in
the trials ranged from 46.5 (14.1) to 50.3 (12.5) years in partici-
pants undergoing total thyroidectomy compared to 45.7 (15.6) to
48.2 (15.4) years in participants undergoing subtotal thyroidec-
tomy. Body mass index (BMI) was not reported. Criteria for entry
into the individual studies are described in the Characteristics of
included studies tables. Major exclusion criteria were Grave’s dis-
ease, Plummer disease, thyroiditis, hyperfunctioning single ade-
noma or cancer.
Diagnosis
Multinodular non-toxic goitre was diagnosed with ultrasono-
graphic examinations and thyroid function tests. One trial did not
report diagnostic procedures (Pappalardo 1998).
Interventions
Total thyroidectomy or near-total thyroidectomy was compared
to subtotal thyroidectomy or the Dunhill procedure or partial
thyroidectomy.
Outcomes
Only Barczynski 2010 explicitly stated primary and secondary
endpoints in the publication. The defined primary outcomes were
recurrent goitre and the need for a redo surgery.
Excluded studies
Ten studies had to be excluded after careful evaluation of the full
publication - see Figure 1. The main reasons for exclusion were:
not a randomised controlled trial, Grave’s disease and wrong inter-
vention or control group (for details see Characteristics of excluded
studies).
Risk of bias in included studies
For details on risk of bias of included studies see Characteristics
of included studies. For an overview of review authors’ judgments
about each risk of bias item for individual studies and across all
studies see Figure 2 and Figure 3. We investigated performance
bias, detection bias and attrition bias separately for objective and
subjective outcome measures.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Two studies utilized adequate methods for random sequence gen-
eration and were rated as low risk of bias ( Barczynski 2010; Giles
2004). None of the studies described the method of allocation
concealment.
Blinding
Only one study explicitly reported that blinding of the participants
and personnel was undertaken (Barczynski 2010). However the
methods used to achieve blinding were not described (Barczynski
2010). No study provided information about blinding of outcome
assessors.
Incomplete outcome data
The numbers of participants discontinuing the trial were described
in two publications (Barczynski 2010; Pappalardo 1998) which
had losses to follow-up of 30 and no participants, respectively. No
publication mentioned the use of an intention-to-treat analysis.
Two studies did not clearly report losses to follow-up (Giles 2004;
Yang 2009). Detailed descriptions of participants’ withdrawals or
reasons underpinning them were not provided in all of the in-
cluded studies. No trial had attrition rates that would have a prob-
able impact on the effect estimates.
Selective reporting
According to the Outcome Reporting Bias In Trials (ORBIT)
classification all included studies had a high risk of bias for certain
outcomes (for details see Appendix 6).
Other potential sources of bias
We did not detect any other additional risk of bias.
Effects of interventions
See: Summary of findings for the main comparison Total or
near-total thyroidectomy compared with subtotal thyroidectomy
for multinodular non-toxic goitre in adults
Baseline characteristics
For details of baseline characteristics, see Appendix 3 andAppendix
4.
We investigated the effects of total and near-total thyroidectomy
versus subtotal thyroidectomy and evaluated the following out-
comes:
Primary outcomes
All-cause mortality
No postoperative hospital deaths or deaths within the first 30
days occurred after total or subtotal thyroidectomy (Analysis 1.1).
However, all-causemortality was notmeasured over longer periods
of follow-up in any of the included trials indicating a high risk of
reporting bias (moderate quality evidence, see Appendix 6).
Goitre recurrence and re-intervention due to goitre
recurrence.
Goitre recurrence was lower in the total thyroidectomy group (OR
0.05 (95% CI 0.01 to 0.21); P < 0.0001; 1057 participants; 3
trials; moderate quality evidence; Analysis 1.2).
Re-intervention due to goitre recurrence, which was only men-
tioned in one included trial, was lower in the total thyroidectomy
group than in the subtotal thyroidectomy group (OR 0.66 (95%
CI 0.07 to 6.38); P = 0.72; 570 participants; 1 trial; low quality
evidence; Analysis 1.3). There was a high risk of outcome report-
ing bias for three of four trials (Giles 2004; Pappalardo 1998; Yang
2009).
Adverse events
The total number of adverse events were lower in the subtotal
thyroidectomy group (OR 1.85 (95%CI 1.17 to 2.92); P = 0.009;
1267 participants; 4 trials; Analysis 1.4).
Postoperative bleeding and red cell transfusions
These outcomes were not evaluated in any of the analysed trials.
Permanent recurrent laryngeal nerve (RLN) palsy
The incidence of permanent RLN palsy was lower in the subtotal
thyroidectomy group (OR 1.28 (95% CI 0.38 to 4.36); P = 0.69;
1275 participants; 4 trials; low quality evidence; Analysis 1.5).
Transient RLNpalsy
The incidence of transient RLN palsy was lower in the subtotal
thyroidectomy group (OR 1.62 (95% CI 0.94 to 2.78); P = 0.08;
1275 participants; 4 trials; Analysis 1.6).
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Permanent hypoparathyroidism
The incidence of permanent hypoparathyroidism was lower in the
subtotal thyroidectomy group (OR 3.09 (95% CI 0.45 to 21.36);
P = 0.25; 1272 participants; 4 trials; low quality evidence; Analysis
1.7).
Transient hypoparathyroidism
The incidence of transient hypoparathyroidism was lower in the
subtotal thyroidectomy group (OR 2.47 (95% CI 1.57 to 3.88);
P < 0.0001; 1275 participants; 4 trials; Analysis 1.8).
Secondary outcomes
Thyroid cancer incidence
The incidence of thyroid cancer was less in the subtotal thyroidec-
tomy group (OR 1.32 (95% CI 0.81 to 2.15); P = 0.27; 1134
participants; 3 trials; low quality evidence; Analysis 1.9).
Health-related quality of life
Health-related quality of life was not measured in any trial.
Socioeconomic effects
Socioeconomic effects were not evaluated in any trial.
Subgroup analyses
We did not perform subgroups analyses because there were not
enough studies to estimate effects in various subgroups.
Sensitivity analyses
We performed sensitivity analyses by examining each outcome us-
ing fixed-effect and random-effects models. There were no sub-
stantial differences in the results between models. Similarly, we
examined how varying the effect size statistic using odds ratio or
relative risk influenced study outcomes. We also found no sub-
stantial differences between effect size measures.
Assessment of reporting bias
Wedid not construct funnel plots due to limited number of studies
per outcome.
D I S C U S S I O N
Summary of main results
A systematic review of the literature identified four RCTs compar-
ing total or near-total thyroidectomy to subtotal thyroidectomy
for the surgical management of non-toxic multinodular goitre
(Barczynski 2010; Giles 2004; Pappalardo 1998; Yang 2009).
The four trials showed some heterogeneity in surgical approaches.
For the purpose of this review participants undergoing total and
near-total thyroidectomy were summarised in the intervention
group and participants undergoing subtotal, partial or Dunhill
thyroidectomy were classified in the comparator group.
Our key outcome measures health-related quality of life and so-
cioeconomic effects were not adequately addressed in the included
trials. Also, postoperative bleeding and the need for transfusion
were not reported. There were no deaths in the short-term post-
operative period up to 30 days after surgery. Goiter recurrence was
higher for subtotal thyroidectomy. Thyroid cancer incidence and
themost important adverse effects (permanent recurrent laryngeal
nerve palsy and permanent hypoparathyroidism) did not differ
substantially when comparing intervention with control groups.
Two of the trials had only a short follow-up period, which must
be taken into consideration especially regarding goitre recurrence
rates and potential surgical re-interventions (Giles 2004; Yang
2009).
Overall completeness and applicability of
evidence
The four included trials reported on most of our primary out-
comes. Only one trial provided data on re-interventions due to
goitre recurrence (Barczynski 2010). As a caveat, there was some
heterogeneity regarding the surgical techniques used by the dif-
ferent study authors: near-total, subtotal, partial and Dunhill thy-
roidectomies can be subjectively interpreted and are operator de-
pendent.
Quality of the evidence
In the postoperative period no deaths were observed. However,
information on all-cause mortality for longer follow-up periods
is missing which was a reason to downgrade the quality of the
evidence to moderate in the Summary of findings for the main
comparison. The data on goitre recurrence were of moderate qual-
ity due to the small number of events and an unknown risk of
detection bias. The body of evidence supporting all other key out-
comes including re-intervention due to goitre recurrence,main ad-
verse events and thyroid cancer incidence was low quality, mainly
because of high risk of outcome reporting bias and serious impre-
cision (i.e. very sparse data).
Potential biases in the review process
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Despite extensive search efforts we might have overlooked unpub-
lished data especially regarding the Chinese literature. Informa-
tion such as the experience of the surgeon performing the thy-
roidectomy would have been essential for the interpretation of the
results but was not available.
Agreements and disagreements with other
studies or reviews
Recently, a systematic review assessing the use of total thyroidec-
tomy (including near-total thyroidectomy) compared to subto-
tal thyroidectomy for the surgical management of multinodular
goitre was reported (Cao 2014). The authors included a mixture
of seven observational and controlled clinical studies, compris-
ing 2192 participants. Total thyroidectomy was associated with
lower nodule recurrence rates (OR 0.13 (95% CI 0.07 to 0.22);
P < 0.001; 1927 participants; 6 trials) and higher transient hy-
poparathyroidism rates (OR 2.33 (95% CI 1.72 to 3.17); P <
0.0001; 2145 participants; 7 trials) which was comparable with
our results. The OR for permanent RLN palsy was 0.81 (95% CI
0.24 to 2.74); P = 0.74; 2145 participants; 7 trials) and the OR
for permanent hypothyroidism was 2.94 (95% CI 0.48 to 18.11);
P = 0.24; 2145 participants; 7 trials). These results were compared
to our own results.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The body of evidence on (near) total thyroidectomy compared
with subtotal thyroidectomy is limited. Moderate quality evidence
indicates that there are no substantial differences between these
surgical techniques on postoperative deaths up to 30 days after
surgery. Goiter recurrence is reduced following (near) total thy-
roidectomy which has to be interpreted with caution due to un-
known risk of detection bias and the small number of events over-
all. The other findings of our review could only partially address
our objectives, mainly because information on re-interventions
due to goitre recurrence, adverse events and thyroid cancer inci-
dence was limited.
Implications for research
Longer follow-up periods were only provided in two trials which
limits the body of evidence especially for the incidence of goitre re-
currence. None of the considered trials described data on all-cause
mortality over longer follow-up periods, health-related quality of
life or socioeconomic effects of the two interventions. Subgroup
analyses would have been vital for the completeness of this review
but data were not reported: the treatment volume of the surgical
centres, participants age, participants body mass index, the tech-
nique used to divide vessels and the surgeons level of experience
may play an important role in postoperative outcomes. New trials
reporting on these aspects are required.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Barczynski 2010
Methods Parallel RCT, superiority design
Participants Inclusion criteria: bilateral non-toxic MNG with the posterior aspects of both thyroid
lobes appearing normal on ultrasound of the neck
Exclusion criteria: MNG involving the posterior aspect/s of thyroid lobe/s, suspicion
of thyroid cancer, previous thyroid surgery, thyroiditis, subclinical or clinically overt
hypothyroidism or hyperthyroidism, pregnancy or lactation, age < 18 years or > 65
years, American Society of Anesthesiology (ASA) grade 4, and a participant’s inability to
comply with the follow-up protocol
Diagnostic criteria: high-resolution doppler ultrasound of the neck. Fine needle aspi-
ration of the thyroid. Serum free T3, free T4 and thyroid-stimulating hormone (TSH);
thyroid peroxidase antibodies levels
Interventions Number of study centres: 1
Treatment before study: not reported
Outcomes Outcomes reported in abstract of publication:
Primary outcome: prevalence of recurrent goitre and need for redo surgery
Secondary outcome: postoperative morbidity rate (hypoparathyroidism and recurrent
laryngeal nerve injury)
Study details Run-in period: none
Study terminated before regular end (for benefit / because of adverse events): no
Publication details Language of publication: English
Non-commercial funding
Publication status: peer-reviewed journal
Stated aim of study Quote from publication: “The aim of the present study was to evaluate results of various
thyroid resectionmodes (Total Thyroidectomy versusDunhill Operation versus Bilateral
Subtotal Thyroidectomy), with special emphasis put on the recurrence rate andmorbidity
rate, in a 5-year follow-up”
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote from publication: “Randomization was per-
formed by computer-generated permuted block se-
quencing”
Comment: unclear block size
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Barczynski 2010 (Continued)
Allocation concealment (selection bias) Unclear risk Quote from publication: “Patients allocated by
opening sealed envelopes in the operating theatre”
Comment: questionable whether envelopes were
opaque and sequentially numbered
Blinding of participants and personnel
(performance bias)
Objective outcomes
Low risk Quote from publication: “All participants were
blinded to treatment assignment for the duration
of the study”
Comment: no information about personnel blind-
ing provided but we judge that the objective out-
comes of this review are not likely to be influenced
by lack of blinding of participants or personnel
Blinding of participants and personnel
(performance bias)
Subjective outcomes
Unclear risk Comment: unclear whether adverse events were
measured by study personnel (potential risk of bias)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Comment: no information
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Comment: no information
Incomplete outcome data (attrition bias)
Objective outcomes
Low risk Comment: during follow-up a total of 30 partic-
ipants were lost to follow-up, the reasons are not
provided in the publication but the number of par-
ticipants lost to follow-up is balanced among treat-
ment arms; it is unlikely that the low attrition rate
affected outcome measures
Incomplete outcome data (attrition bias)
Subjective outcomes
Low risk Comment: during follow-up a total of 30 partic-
ipants were lost to follow-up, the reasons are not
provided in the publication but the number of par-
ticipants lost to follow-up is balanced among treat-
ment arms; it is unlikely that the low attrition rate
affected outcome measures
Selective reporting (reporting bias) High risk Comment: high risk of bias for outcome measure
all-cause mortality according to the ORBIT classi-
fication (see Appendix 6)
Other bias Low risk Comment: none detected
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Giles 2004
Methods Parallel RCT, superiority design
Participants Inclusion criteria: nontoxic MNG
Exclusion criteria: no history of hyperthyroidism, radiation exposure, familial thyroid
cancer, preoperative or perioperative suspicion of cancer
Diagnostic criteria: ultrasonography examination (multinodular hyperplasia of the thy-
roid gland)
Interventions Number of study centres: 1
Treatment before study: not reported
Outcomes Outcomes reported in abstract of publication: transient recurrent laryngeal nerve
paralysis, transient hypocalcaemia symptoms, permanent recurrent laryngeal nerve paral-
ysis, permanent hypoparathyroidism, papillary cancer, goitre recurrence, reoperation or
radioactive iodine ablation for goitre recurrence
Study details Run-in period: none
Study terminated before regular end (for benefit / because of adverse events): no
Publication details Language of publication: English
Non-commercial funding
Publication status: peer-reviewed journal
Stated aim of study Quote from publication: “To investigate the impact of total thyroidectomy on the rate
of completion thyroidectomy for incidentally found thyroid cancer in euthyroid multin-
odular goiter”
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote frompublication: “Patients were selected ac-
cording to the number on the random table for 2
different extensions of surgical procedures”
Allocation concealment (selection bias) Unclear risk Comment: information about allocation conceal-
ment not provided
Blinding of participants and personnel
(performance bias)
Objective outcomes
Unclear risk Comment: information about blinding of person-
nel and participants not provided
Blinding of participants and personnel
(performance bias)
Subjective outcomes
Unclear risk Comment: information about blinding of person-
nel and participants not provided
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Giles 2004 (Continued)
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Comment: information about blinding of outcome
assessment not provided
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Comment: information about blinding of outcome
assessment not provided
Incomplete outcome data (attrition bias)
Objective outcomes
Low risk Comment: no drop-outs
Incomplete outcome data (attrition bias)
Subjective outcomes
Low risk Comment: no drop-outs
Selective reporting (reporting bias) High risk Comment: high risk of bias for outcome mea-
sures all-cause mortality and re-intervention due to
goitre recurrence according to the ORBIT classifi-
cation (see Appendix 6)
Other bias Low risk Comment: none detected
Pappalardo 1998
Methods Parallel RCT, superiority design
Participants Inclusion criteria: unilateral and bilateral multinodular euthyroid goitres
Exclusion criteria: graves’ disease, Plummer disease, thyroiditis, hyperfunctioning single
adenoma or cancer
Diagnostic criteria: not reported
Interventions Number of study centres: 1
Treatment before study: not reported
Outcomes Outcomes reported in abstract of publication: temporary or permanent palsy of the
recurrent laryngeal nerve, temporary or permanent hypoparathyroidism, recurrence of
the goitre, and the incidence of iatrogenic injuries after completion thyroidectomy
Study details Run-in period: none
Study terminated before regular end: no
Publication details Language of publication: English
Non-commercial funding
Publication status: peer-reviewed journal
Stated aim of study Quote from publication: “To evaluate the outcome after total and subtotal thyroidec-
tomy for the treatment of single and multinodular goitres in two comparable groups of
patients”
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Pappalardo 1998 (Continued)
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote from publication: “The patients were ran-
domly assigned to have total thyroidectomy or
subtotal thyroidectomy”
Comment: the procedure to perform randomisa-
tion is not described
Allocation concealment (selection bias) Unclear risk Comment: information about allocation conceal-
ment not provided
Blinding of participants and personnel
(performance bias)
Objective outcomes
Unclear risk Comment: information about blinding of partici-
pants and personnel not provided
Blinding of participants and personnel
(performance bias)
Subjective outcomes
Unclear risk Comment: information about blinding of partici-
pants and personnel not provided
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Comment: information about blinding of outcome
assessment not provided
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Comment: information about blinding of partici-
pants and personnel not provided
Incomplete outcome data (attrition bias)
Objective outcomes
Low risk Comment: no missing outcome data, all partici-
pants completed the follow-up
Incomplete outcome data (attrition bias)
Subjective outcomes
Low risk Comment: no missing outcome data, all partici-
pants completed the follow-up
Selective reporting (reporting bias) High risk Comment: high risk of bias for outcome mea-
sures all-cause mortality and re-intervention due to
goitre recurrence according to the ORBIT classifi-
cation (see Appendix 6)
Other bias Low risk Comment: none detected
25Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Yang 2009
Methods Parallel RCT, superiority design
Participants Inclusion criteria: bilateral multinodular goitre
Exclusion criteria: no history of thyroidectomy
Diagnostic criteria: ultrasonography examination (a bilateral multinodular goitre)
Interventions Number of study centres: 1
Treatment before study: not reported
Outcomes Outcomes reported in abstract of publication: transient recurrent laryngeal nerve
paralysis, transient hypocalcaemia symptoms, permanent hypoparathyroidism, goitre
recurrence
Study details Run-in period: none
Study terminated before regular end (for benefit / because of adverse events): no
Publication details Language of publication: English
Non-commercial funding
Publication status: peer-reviewed journal
Stated aim of study “To evaluate the feasibility and safety of total and near-total bilateral thyroidectomy for
the treatment of bilateral multinodular goiter.”
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote from publication: “... patients with a di-
agnosis of bilateral multinodular goiter were ran-
domly divided into two groups ..”
Comment: the procedure to perform randomisa-
tion is not described
Allocation concealment (selection bias) Unclear risk Comment: information about allocation conceal-
ment not provided
Blinding of participants and personnel
(performance bias)
Objective outcomes
Unclear risk Comment: information about blinding of partici-
pants and personnel not provided
Blinding of participants and personnel
(performance bias)
Subjective outcomes
Unclear risk Comment: information about blinding of partici-
pants and personnel not provided
Blinding of outcome assessment (detection
bias)
Objective outcomes
Unclear risk Comment: information about blinding of outcome
assessment not provided
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Yang 2009 (Continued)
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Comment: information about blinding of outcome
assessment not provided
Incomplete outcome data (attrition bias)
Objective outcomes
Low risk Comment: no drop-outs
Incomplete outcome data (attrition bias)
Subjective outcomes
Low risk Comment: no drop-outs
Selective reporting (reporting bias) High risk Comment: high risk of bias for outcome mea-
sures all-cause mortality and re-intervention due to
goitre recurrence according to the ORBIT classifi-
cation (see Appendix 6)
Other bias Low risk Comment: none detected
ASA: American Society of Anesthesiology; MNG: multinodular nontoxic goitre; ORBIT: Outcome Reporting Bias In Trials; RCT:
randomised controlled trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Barczynski 2012 In this RCT bilateral subtotal thyroidectomy is compared with total thyroidectomy for the surgical management
of Grave’s disease
Chi 2005 In thisRCTbilateral subtotal thyroidectomy is comparedwith hemithyroidectomyplus subtotal resection (Dunhill
procedure) for the surgical management of Grave’s disease
Erbil 2006 In this RCT total thyroidectomy is compared with near-total thyroidectomy for the surgical management of
multinodular goitre
Rayes 2013 In thisRCTbilateral subtotal thyroidectomy is comparedwith hemithyroidectomyplus subtotal resection (Dunhill
procedure) for the surgical management of bilateral multinodular goitre
Rouwen 2011 A systematic review on surgical approach for treating multinodular goitre: total thyroidectomy/near- total thy-
roidectomy with subtotal thyroidectomy/bilateral subtotal thyroidectomy/Dunhill procedure
Sancho 2012 In this RCThemithyroidectomy is comparedwith hemithyroidectomy plus subtotal resection (Dunhill procedure)
for the surgical management of asymmetrical multinodular goitre
Tezelman 2009 A retrospective cohort study comparing subtotal versus near-total or total thyroidectomy in the treatment of
patients with multinodular goitre
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(Continued)
Unalp 2009 In this RCT total thyroidectomy is compared with near-total thyroidectomy for the surgical management of
multinodular goitre
Vaiman 2008 A retrospective cohort study comparing subtotal versus near-total thyroidectomy in the treatment of patients with
multinodular goitre
Witte 2000 In this RCT total thyroidectomy is compared with subtotal resection for the surgical management of Grave’s
disease
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Overall post-operative mortality 4 Odds Ratio (M-H, Random, 95% CI) Totals not selected
2 Goitre recurrence 3 1057 Odds Ratio (M-H, Random, 95% CI) 0.05 [0.01, 0.21]
3 Re-intervention due to goitre
recurrence
1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
4 Adverse events 4 1267 Odds Ratio (M-H, Random, 95% CI) 1.85 [1.17, 2.92]
5 Permanent recurrent laryngeal
nerve palsy
4 1275 Odds Ratio (M-H, Random, 95% CI) 1.28 [0.38, 4.36]
6 Transient recurrent laryngeal
nerve palsy
4 1275 Odds Ratio (M-H, Random, 95% CI) 1.62 [0.94, 2.78]
7 Permanent hypoparathyroidism 4 1275 Odds Ratio (M-H, Random, 95% CI) 3.09 [0.45, 21.36]
8 Transient hypoparathyroidism 4 1275 Odds Ratio (M-H, Random, 95% CI) 2.47 [1.57, 3.88]
9 Thyroid cancer incidence 3 1134 Odds Ratio (M-H, Random, 95% CI) 1.32 [0.81, 2.15]
Analysis 1.1. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 1 Overall
post-operative mortality.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 1 Overall post-operative mortality
Study or subgroup
(Near)Total
thyroidec-
tomy
Subtotal
thyroidec-
tomy Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barczynski 2010 0/200 0/400 Not estimable
Giles 2004 0/109 0/109 Not estimable
Pappalardo 1998 0/69 0/72 Not estimable
Yang 2009 0/165 0/181 Not estimable
0.01 0.1 1 10 100
Favours total thyroid. Favours subtotal thyroid.
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Analysis 1.2. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 2 Goitre
recurrence.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 2 Goitre recurrence
Study or subgroup Favours total thyroid.
Subtotal
thyroidec-
tomy Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Pappalardo 1998 0/69 10/72 24.6 % 0.04 [ 0.00, 0.75 ]
Yang 2009 0/165 12/181 25.0 % 0.04 [ 0.00, 0.70 ]
Barczynski 2010 1/191 31/379 50.3 % 0.06 [ 0.01, 0.44 ]
Total (95% CI) 425 632 100.0 % 0.05 [ 0.01, 0.21 ]
Total events: 1 (Favours total thyroid.), 53 (Subtotal thyroidectomy)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.06, df = 2 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 4.15 (P = 0.000034)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours total thyroid. Favours subtotal thyroid.
Analysis 1.3. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 3 Re-
intervention due to goitre recurrence.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 3 Re-intervention due to goitre recurrence
Study or subgroup Favours total thyroid.
Subtotal
thyroidec-
tomy Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barczynski 2010 1/191 3/379 0.66 [ 0.07, 6.38 ]
0.005 0.1 1 10 200
Favours total thyroid. Favours subtotal thyroid.
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Analysis 1.4. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 4 Adverse
events.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 4 Adverse events
Study or subgroup
(Near)Total
thyroidec-
tomy
Subtotal
thyroidec-
tomy Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barczynski 2010 47/191 44/379 43.8 % 2.49 [ 1.58, 3.92 ]
Giles 2004 2/109 3/109 5.9 % 0.66 [ 0.11, 4.03 ]
Pappalardo 1998 28/69 17/72 26.2 % 2.21 [ 1.07, 4.57 ]
Yang 2009 14/159 14/179 24.1 % 1.14 [ 0.52, 2.47 ]
Total (95% CI) 528 739 100.0 % 1.85 [ 1.17, 2.92 ]
Total events: 91 ((Near)Total thyroidectomy), 78 (Subtotal thyroidectomy)
Heterogeneity: Tau2 = 0.07; Chi2 = 4.43, df = 3 (P = 0.22); I2 =32%
Test for overall effect: Z = 2.63 (P = 0.0086)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours total thyroid. Favours subtotal thyroid.
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Analysis 1.5. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 5
Permanent recurrent laryngeal nerve palsy.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 5 Permanent recurrent laryngeal nerve palsy
Study or subgroup
(Near)Total
thyroidec-
tomy
Subtotal
thyroidec-
tomy Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barczynski 2010 4/191 5/379 85.5 % 1.60 [ 0.42, 6.03 ]
Giles 2004 0/109 0/109 Not estimable
Pappalardo 1998 0/69 1/72 14.5 % 0.34 [ 0.01, 8.56 ]
Yang 2009 0/165 0/181 Not estimable
Total (95% CI) 534 741 100.0 % 1.28 [ 0.38, 4.36 ]
Total events: 4 ((Near)Total thyroidectomy), 6 (Subtotal thyroidectomy)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.76, df = 1 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 0.39 (P = 0.69)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours total thyroid. Favours subtotal thyroid.
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Analysis 1.6. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 6
Transient recurrent laryngeal nerve palsy.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 6 Transient recurrent laryngeal nerve palsy
Study or subgroup
(Near)Total
thyroidec-
tomy
Subtotal
thyroidec-
tomy Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barczynski 2010 21/191 24/379 77.6 % 1.83 [ 0.99, 3.37 ]
Giles 2004 1/109 1/109 3.8 % 1.00 [ 0.06, 16.19 ]
Pappalardo 1998 2/69 2/72 7.4 % 1.04 [ 0.14, 7.63 ]
Yang 2009 3/165 3/181 11.2 % 1.10 [ 0.22, 5.52 ]
Total (95% CI) 534 741 100.0 % 1.62 [ 0.94, 2.78 ]
Total events: 27 ((Near)Total thyroidectomy), 30 (Subtotal thyroidectomy)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.67, df = 3 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.75 (P = 0.081)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours total thyroid. Favours subtotal thyroid.
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Analysis 1.7. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 7
Permanent hypoparathyroidism.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 7 Permanent hypoparathyroidism
Study or subgroup
(Near)Total
thyroidec-
tomy
Subtotal
thyroidec-
tomy Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barczynski 2010 1/191 0/379 36.4 % 5.98 [ 0.24, 147.40 ]
Giles 2004 0/109 0/109 Not estimable
Pappalardo 1998 2/69 1/72 63.6 % 2.12 [ 0.19, 23.92 ]
Yang 2009 0/165 0/181 Not estimable
Total (95% CI) 534 741 100.0 % 3.09 [ 0.45, 21.36 ]
Total events: 3 ((Near)Total thyroidectomy), 1 (Subtotal thyroidectomy)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.26, df = 1 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 1.14 (P = 0.25)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
Favours total thyroid. Favours subtotal thyroid.
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Analysis 1.8. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 8
Transient hypoparathyroidism.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 8 Transient hypoparathyroidism
Study or subgroup
(Near)Total
thyroidec-
tomy
Subtotal
thyroidec-
tomy Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Barczynski 2010 21/191 12/379 38.1 % 3.78 [ 1.82, 7.86 ]
Giles 2004 2/109 1/109 3.5 % 2.02 [ 0.18, 22.60 ]
Pappalardo 1998 24/69 13/72 33.7 % 2.42 [ 1.11, 5.27 ]
Yang 2009 11/165 9/181 24.8 % 1.37 [ 0.55, 3.38 ]
Total (95% CI) 534 741 100.0 % 2.47 [ 1.57, 3.88 ]
Total events: 58 ((Near)Total thyroidectomy), 35 (Subtotal thyroidectomy)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.96, df = 3 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 3.93 (P = 0.000086)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours total thyroid. Favours subtotal thyroid.
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Analysis 1.9. Comparison 1 (Near) Total thyroidectomy versus subtotal thyroidectomy, Outcome 9 Thyroid
cancer incidence.
Review: Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults
Comparison: 1 (Near) Total thyroidectomy versus subtotal thyroidectomy
Outcome: 9 Thyroid cancer incidence
Study or subgroup Favours total thyroid.
Subtotal
thyroidec-
tomy Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Giles 2004 10/109 8/109 25.6 % 1.28 [ 0.48, 3.36 ]
Yang 2009 6/165 2/181 9.3 % 3.38 [ 0.67, 16.97 ]
Barczynski 2010 18/191 31/379 65.1 % 1.17 [ 0.64, 2.15 ]
Total (95% CI) 465 669 100.0 % 1.32 [ 0.81, 2.15 ]
Total events: 34 (Favours total thyroid.), 41 (Subtotal thyroidectomy)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.47, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 1.10 (P = 0.27)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours total thyroid. Favours subtotal thyroid.
A D D I T I O N A L T A B L E S
Table 1. Overview of study populations
Interven-
tion(s)
and com-
parator(s)
Sample
sizea
Screened/
eligible
[N]
Ran-
domised
[N]
Safety
[N]
ITT
[N]
Finishing
study
[N]
Ran-
domised
finishing
study
[%]
Follow-up
time
(1) Bar-
czynski
2010
I: total thy-
roidec-
tomy
b 3133 200 200 - 191 95 5 years
C1: Dun-
hill proce-
dure
200 200 - 189 94
C2: bilat-
eral subto-
tal
thyroidec-
200 200 - 190 95
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Table 1. Overview of study populations (Continued)
tomy
total: 600 600 - 570 95
(2) Giles
2004
I: total or
near total
thyroidec-
tomy
- - 109 109 - 109 100 1-3 years
C: subtotal
thyroidec-
tomy
109 109 - 109 100
total: 218 218 - 218 100
(3) Pap-
palardo
1998
I: total or
near total
thyroidec-
tomy
- - 69 69 - 69 100 10 years
C: bilateral
subtotal
thyroidec-
tomy
72 72 - 72 100
total: 141 141 - 141 100
(4) Yang
2009
I: total or
near total
thyroidec-
tomy
- - 165 165 - 165 100 I:
median fol-
low-up 36
months
C: subtotal
thyroidec-
tomy
181 181 - 181 100 C: median
follow-up
39 months
total: 346 346 - 346 100
Grand to-
tal
All inter-
ventions
543 534 98
All c om-
parators
762 741 97
All inter-
ventions
and c om-
parators
1305 1275 98
aAccording to power calculation in study publication or report
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bQuote from publication: “The sample size was estimated based on the principle of detecting a 5% difference in the prevalence of
recurrent goiter with a 90% probability at P < 0.05”; comment: no sample size provided
“-” denotes not reported
C: comparator; I: intervention; ITT: intention-to-treat
A P P E N D I C E S
Appendix 1. Search strategies
Cochrane Library (Wiley)
1. [mh ˆ“Goiter, Nodular”]
2. [mh ˆ“Thyroid Nodule”]
3. ((goiter* or goitre*) near/7 (nodul* or multinodul* or multi nodul* or “nontoxic” or “non toxic”)):ti,ab,kw
4. {or #1-#3}
5. [mh ˆ“Thyroidectomy”]
6. thyroidectom*:ti,ab,kw
7. surg*:ti,ab,kw
8. {or #5-#7}
9. #4 and #8
MEDLINE (Ovid SP)
1. Goiter, Nodular/
2. Thyroid Nodule/
3. ((goiter* or goitre*) adj6 (nodul* or multinodul* or multi nodul* or nontoxic or non toxic)).tw.
4. or/1-3
5. Thyroidectomy/
6. thyroidectom*.tw.
7. surg*.tw.
8. or/5-7
9. 4 and 8
[10-19: Cochrane Handbook 2008 RCT filter - sensitivity maximizing version, without “drug therapy.fs.”]
10. randomized controlled trial.pt.
11. controlled clinical trial.pt.
12. randomi?ed.ab.
13. placebo.ab.
14. randomly.ab.
15. trial.ab.
16. groups.ab.
17. or/10-16
18. exp animals/ not humans/
19. 17 not 18
20. 9 and 19
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(Continued)
PubMed Search Strategy
(only subsets not available on Ovid SP)
#1 ((goiter*[tiab] OR goitre*[tiab] OR thyroid*[tiab]) AND (nodul*[tiab] OR multinodul*[tiab] OR multi nodul*[tiab] OR non-
toxic[tiab] OR non toxic[tiab]))
#2 thyroidectom*[tiab] OR surg*[tiab]
#3 #1 AND #2
#4 random*[tiab] OR trial[tiab] OR groups[tiab]
#5 #3 AND #4
#6 #5 NOT medline[sb] NOT pmcbook
EMBASE (Ovid SP)
1. Nodular goiter/
2. Thyroid nodule/
3. ((goiter* or goitre*) adj6 (nodul* or multinodul* or multi nodul* or nontoxic or non toxic)).tw.
4. or/1-3
5. Thyroidectomy/
6. Subtotal thyroidectomy/
7. thyroidectom*.tw.
8. surg*.tw.
9. or/5-8
10. 4 and 9
[11: Wong et al. 2006 “sound treatment studies” filter - SDSSGS version]
11. random*.tw. or clinical trial*.mp. or exp treatment outcome/
12. 10 and 11
13. limit 12 to embase
ICTRP Search Portal
Standard search:
goit* AND nodul* AND thyroidectom* OR
goit* AND nodul* AND surg* OR
goit* AND multinodul* AND thyroidectom* OR
goit* AND multinodul* AND surg* OR
goit* AND nontoxic AND thyroidectom* OR
goit* AND nontoxic AND surg* OR
goit* AND non toxic AND thyroidectom* OR
goit* AND non toxic AND surg*
ClinicalTrials.gov
Advanced Search:
Conditions: (goiter OR goitre OR goiters OR goitres) AND (multinodular OR nodular ORmultinodules OR nodules OR nontoxic
OR “non toxic”)
Interventions: thyroidectomy OR thyroidectomies OR surgery OR surgical OR surgeries
Age Group: Adult + Senior
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Appendix 2. Description of interventions
Intervention(s) Comparator(s)
Barczynski 2010 Total thyroidectomy (extracapsular thyroidectomy) C1: Dunhill procedure
C2: bilateral subtotal thyroidectomy
Giles 2004 Total or near-total thyroidectomy (extracapsular thy-
roidectomy)
Subtotal thyroidectomy (the total amount of remnant
thyroid tissue was intended to be ≥ 5 g)
Pappalardo 1998 Total thyroidectomy (extracapsular thyroidectomy) Subtotal thyroidectomy ( leaving 3-5 g on the less af-
fected side)
Yang 2009 Total or near-total thyroidectomy (extracapsular- thy-
roidectomy or -small remnant of thyroid tissue < 1 mg)
Subtotal thyroidectomy
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
Appendix 3. Baseline characteristics (I)
Intervention
(s) and com-
parator(s)
Duration of
follow-up
Participating
population
Study period
[year to year]
Country Setting Duration of
MNG
Barczynski
2010
I: total thy-
roidectomy
5 years Bilateral non-
toxic MNG
2000 to 2003 Poland De-
partment of en-
docrine surgery,
tertiary referral
centre
-
C1: Dunhill
procedure
C2: bi-
lateral subto-
tal thyroidec-
tomy
Giles 2004 I: (near) to-
tal thyroidec-
tomy
1-3 years Multinodular
eu-
thyroid goitre
with or with-
out a domi-
nant nodule
2003 to 2005 Turkey Departments of
general surgery
and endocrinol-
ogy, tertiary re-
ferral centre
-
C: subto-
tal thyroidec-
tomy
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(Continued)
Pappalardo
1998
I: total thy-
roidectomy
10 years Unilateral and
bi-
lateral multin-
odular euthy-
roid goitre
1975 to 1985 Italy Surgical clinic &
depart-
ment of internal
medicine, ter-
tiary referral cen-
tre
-
C: subto-
tal thyroidec-
tomy
Yang 2009 I: (near) to-
tal thyroidec-
tomy
Median
follow-up 36
months
Bilateral non-
toxic MNG
2003 to 2006 China Departments of
gen-
eral surgery, clin-
ical and molec-
ular pharmacol-
ogy and pathol-
ogy, tertiary re-
ferral centre
-
C: subto-
tal thyroidec-
tomy
Median
follow-up 39
months
“-” denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention; MNG: multinodular nontoxic goitre
Appendix 4. Baseline characteristics (II)
Intervention(s)
and comparator
(s)
Sex
[female %]
Age
[mean/range
years (SD),
or as reported]
Thyroid volume
[mean ml (SD)]
Comedications/
Cointerven-
tions
Comorbidities
Barczynski
2010
I: total
thyroidectomy
91 46.5(14.1) 76.6 (38.9) All participants,
ir-
respective of the
individual group
assignment, re-
ceived postoper-
ative levothyrox-
ine treatment at a
dose adjusted to
the serum TSH
concentration to
keep it within
the lowest two-
thirds of the ref-
erence range (0.
3-2.5 mU/L)
-
C1:Dunhill pro-
cedure
89 47.2 (15.6) 77.8 (39.5)
C2:
bilateral subtotal
thyroidectomy
91 48.2 (15.4) 78.9 (40.1)
Giles 2004 I: (near) total
thyroidectomy
86 50.3 (12.5) - Suppres-
sive doses of thy-
-
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(Continued)
roid hormone for
some par-
ticipants (e.g. pa-
tients with non-
invasive micro-
carcinoma with-
out radioiodine
ablation)
C: subtotal thy-
roidectomy
84 45.7 (12.1)
Pappalardo
1998
I: total
thyroidectomy
71 Mean 48 (25-67) - All patients were
discharged
taking L-thyrox-
ine 1.5-2.25 µg/
kg body weight
daily; dose of L-
thyroxine was
subsequently ad-
justed de-
pending on the
concentration of
circulating TSH;
higher doses of
L-thyroxine were
prescribed
for patients who
had subtotal re-
sections (TSH <
0.8 mU/L) and
lower
doses to patients
who had total
thyroidectomy
and to older and
postmenopausal
patients with the
risk of iatrogenic
osteoporosis
-
C: subtotal thy-
roidectomy
71 Median 50 (27-
70)
Yang 2009 I: (near) total
thyroidectomy
78 22-72 - Thyroxine sub-
stitutionwas pre-
scribed to those
with insufficient
thyroid function
-
C: subtotal thy-
roidectomy
77
“-” denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention; SD: standard deviation; TSH: thyroid-stimulating hormone
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Appendix 5. Matrix of study endpoints (publications and trial documents)
Endpoints quoted
in trial document
(s)
(ClinicalTri-
als.gov, FDA/EMA
document, manu-
facturer’s web-
site, published de-
sign paper)a
Study re-
sults posted in trial
register
[Yes/No]
Publications speci-
fied in trial register
[Yes/No]
Endpoints quoted
in publication(s)b,c
Endpoints quoted
in abstract of pub-
lication(s)b,c
Barczynski 2010 Source:
NCT00946894
Primary outcome
measure(s):
prevalence of recur-
rent goiter and need
for redo
surgery (time frame:
at 12, 24, 36, 48
and 60 months after
surgery)
No Yes Primary outcome
measure(s):
prevalence of recur-
rent goiter and need
for redo surgery
Primary outcome
measure(s):
prevalence of recur-
rent goiter and need
for redo surgery
Secondary out-
come measure(s):
post-
operative morbidity
rate (hypoparathy-
roidism and recur-
rent laryngeal nerve
injury - time frame:
at 3, 6, 9, 12, 24, 36,
48 and 60 months
after surgery)
Secondary out-
come measure(s):
post-
operative morbidity
rate (hypoparathy-
roidism and recur-
rent laryngeal nerve
injury)
Secondary out-
come measure(s):
post-
operative morbidity
rate (hypoparathy-
roidism and recur-
rent laryngeal nerve
injury
Other outcome
measure(s):
-
Other outcome
measure(s):
serum TSH; serum
calcium level; oper-
ative time; haemor-
rhage
Other outcome
measure(s):
-
Giles 2004 N/T Primary outcome
measure(s):
-
Primary outcome
measure(s):
-
Secondary out-
come measure(s):
-
Secondary out-
come measure(s):
-
43Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Other outcome
measure(s):
postoperative com-
plications (perma-
nent/temporary hy-
poparathy-
roidism and perma-
nent/temporary vo-
cal cord paralysis);
thyrotropin; serum
thyroglobulin;
incidence of thyroid
cancer, difference in
the rate of thyroid
cancer requiring ra-
dioactive iodine ab-
lation and comple-
tion thyroidectomy;
operation for benign
goitre
Other outcome
measure(s):
compli-
cation rates (perma-
nent/temporary hy-
poparathy-
roidism and perma-
nent/temporary vo-
cal cord paralysis);
incidence of thyroid
cancer requiring ra-
dioactive iodine ab-
lation and comple-
tion thyroidectomy
Pappalardo 1998 N/T Primary outcome
measure(s):
-
Primary outcome
measure(s):
-
Secondary out-
come measure(s):
-
Secondary out-
come measure(s):
-
Other outcome
measure(s):
recurrence rate after
subto-
tal resection; serum
calcium concentra-
tions; measurement
of parathyroid hor-
mone; triiodothyro-
nine (T3), thyroxine
(T4) and TSH con-
centrations; postop-
erative stay in hospi-
tal; rate of injuries to
the recurrent nerve;
hypothyroidism; re-
operations
in the subtotal group
the rate of injuries to
Other outcome
measure(s):
temporary or per-
manent palsy of the
recurrent laryngeal
nerve; temporary or
perma-
nent hypoparathy-
roidism; recurrence
of the goitre; inci-
dence of ia-
trogenic injuries af-
ter completion thy-
roidectomy
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(Continued)
the recurrent
nerve, hypoparathy-
roidism, and recur-
rences were the only
variables evaluated
Yang 2009 N/T Primary outcome
measure(s):
-
Primary outcome
measure(s):
-
Secondary out-
come measure(s):
-
Secondary out-
come measure(s):
-
Other outcome
measure(s):
serum concentra-
tions of thyroid hor-
mone parame-
ters, such as free tri-
iodothyronine
(FT3), free thyrox-
ine (FT4), and su-
persensitive thyroid-
stimulat-
ing hormone (TSH)
; vocal cord mo-
bility, transient/per-
manent recurrent la-
ryngeal nerve palsy;
serum calcium/hy-
poparathyroidism;
recurrence rate
Other outcome
measure(s):
incidences of post-
operative complica-
tions and recurrence
rate; thyroid can-
cer; transient recur-
rent laryngeal nerve
paralysis;
injury to superior la-
ryngeal nerve; tran-
sient hypocalcaemia
symptoms; perma-
nent hypoparathy-
roidism; recurrence
- denotes not reported
aTrial document(s) refers to all available information from published design papers and sources other than regular publications (e.g.
FDA/EMA documents, manufacturer’s websites, trial registers)
bPublication(s) refers to trial information published in scientific journals (primary reference, duplicate publications, companion
documents or multiple reports of a primary study)
cOther outcome measures refer to all outcomes not specified as primary or secondary outcome measures
EMA: European Medicines Agency; FDA: Food and Drug Administration (US); N/T: no trial document available; TSH: thyroid-
stimulating hormone
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Appendix 6. High risk of outcome reporting bias according to ORBIT classification
Outcome High risk of bias
(category A)a
High risk of bias
(category D)b
High risk of bias
(category E)c
High risk of bias
(category G)d
Barczynski 2010 All-cause mortality x
Giles 2004 All-cause mortality x
Re-intervention due
to goitre recurrence
x
Pappalardo 1998 All-cause mortality x
Re-intervention due
to goitre recurrence
x
Yang 2009 All-cause mortality x
Re-intervention due
to goitre recurrence
x
aClear that outcome was measured and analysed; trial report states that outcome was analysed but only reports that result was not
significant
(Classification ’A’, table 2, Kirkham 2010)
bClear that outcome was measured and analysed; trial report states that outcome was analysed but no results reported
(Classification ’D’, table 2, Kirkham 2010)
cClear that outcome was measured; clear that outcome was measured but not necessarily analysed; judgement says likely to have been
analysed but not reported because of non-significant results
(Classification ’E’, table 2, Kirkham 2010)
dUnclear whether the outcome was measured; not mentioned but clinical judgement says likely to have been measured and analysed
but not reported on the basis of non-significant results
(Classification ’G’, table 2, Kirkham 2010)
N/A: not applicable; ORBIT: Outcome Reporting Bias In Trials
Appendix 7. Definition of endpoint measurement
Goitre
recurrence
Re-intervention
due to goitre re-
currence
Transient
recurrent laryn-
geal nerve palsy
Transient
hypoparathy-
roidism
Health-related
quality of life
Severe/serious
adverse events
Barczynski
2010
“Presence of hy-
poechoic or hy-
perechoic nodu-
lar
pattern at least 5
Completion thy-
roidectomy;
presence of
a 3 cm or larger
nodule; result of
Vocal cord pare-
sis for ≤ 12
months after the
op-
eration; indirect
Hypocal-
caemia for ≤ 6
months after the
operation; pa-
tients were mon-
N/I Vocal cord pare-
sis for more than
12 months af-
ter the operation
was regarded as
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(Continued)
mm in diameter,
identification of
perinodular hy-
poechogenic or
hyperechogenic
halo, and pres-
ence of an ane-
choic lesion with
a reinforced pos-
terior wall”
FNA suggestive
of an increased
risk for malig-
nancy; and pres-
ence of compres-
sive symptoms
laryngoscopy by
a throat special-
ist was manda-
tory be-
fore surgery and
on day 2 postop-
eratively; in pa-
tients with RLN
paresis, addi-
tional examina-
tions were sched-
uled at 2 weeks
and 1, 2, 4, 6,
and 12 months
after surgery, or
until the vocal
cord function re-
covered
i-
tored for postop-
erative biochem-
ical hypocal-
caemia at 12, 24,
48, and 72 h
(during hospital-
ization and af-
ter discharge on
morning outpa-
tient
visits)
, with hypocal-
caemia being de-
fined as a to-
tal serum cal-
cium level less
than2.0mmol/L
in either asymp-
tomatic or symp-
tomatic patients
(perioral or fin-
gertip paraesthe-
sia or numbness,
tetany,
a newly positive
Chvostek sign)
permanent palsy
Persistent
hypocalcaemia
for more than 6
months after the
operation was re-
garded as perma-
nent
hypoparathy-
roidism
Giles 2004 N/I N/I Not explained Not explained N/I Not explained
Pappalardo
1998
Goitre re-
currence was di-
agnosed “when
physical exami-
nation or follow-
up ultrasound
scan showed
nodular involve-
ment or an en-
largement of the
residual thyroid
remnant”
Completion thy-
roidectomy
“A palsy of the
vocal cord diag-
nosed by an oto-
laryngologist
that lasted less
than six months
postoperatively”
“A fall
in the serum cal-
cium concentra-
tion (less than 2.
1 mmol/L) cor-
rected according
to the serum al-
bumin concen-
tration”
N/I “Permanent in-
jury to the recur-
rent
nerve was con-
sidered as palsy
of the vocal cord
diagnosed by an
otolaryngol-
ogist that lasted
for more than six
months postop-
eratively”
“Permanent hy-
poparathy-
roidism as the
need for oral vi-
tamin D and cal-
cium six months
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after the opera-
tion”
Yang 2009 “The recurrence
was defined as
de novo nodules
more than 3 mm
in remnant thy-
roid”
N/I “Those who dis-
played weak mo-
bility for less
than twomonths
after surgery”
“If patients re-
quired an oral or
venous calcium
sup-
plement for less
than 2 months”
N/I “Those who dis-
played weak mo-
bility within 2
months af-
ter surgery were
consid-
ered to have per-
manent RLN in-
jury”
“Permanent hy-
poparathy-
roidism if the
patients required
an oral or venous
calcium supple-
ment and vita-
min D for more
than 2 months
with unde-
tectable plasma
parathyroid hor-
mone levels”
FNA: fine needle aspiration: N/I: not investigated; RLN: recurrent laryngeal nerve
Appendix 8. Adverse events (I)
Interven-
tion(s) and
comparator
(s)
Par-
ticipants in-
cluded in
analysis
[N]
Deaths
[N]
Deaths
[%]
All adverse
events
[N]
All adverse
events
[%]
Severe/
serious
adverse
events
[N]
Severe/
serious
adverse
events
[%]
Barczynski
2010
I: total thy-
roidectomy
191 0 0 47 24.6 4 2.1
C1: Dunhill
procedure
189 0 0 28 14.8 4 2.1
C2: bilateral
subtotal thy-
roidectomy
190 0 0 16 8.4 5 2.6
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all: 570 0 0 91 16 13 2.3
Giles 2004 I: (near) to-
tal thy-
roidectomy
109 0 0 28 27 0 0
C:
subtotal thy-
roidectomy
119 0 0 12 11 0 0
all: 218 0 0 40 18.3 0 0
Pappalardo
1998
I: total thy-
roidectomy
69 0 0 28 40.6 2 2.9
C:
subtotal thy-
roidectomy
72 0 0 17 23.6 2 2.7
all: 141 0 0 45 31.9 4 2.8
Yang 2009 I: (near) to-
tal thy-
roidectomy
165 0 0 14 8.8 - -
C:
subtotal thy-
roidectomy
181 0 0 12 6.7 2 1.1
all: 346 0 0 26 7.5 N/A N/A
“-” denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention; N/A: not applicable
Appendix 9. Adverse events (II)
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Interven-
tion(s) and
comparator
(s)
Par-
ticipants in-
cluded in
analysis
[N]
Partic-
ipants dis-
contin-
uing study
due to ad-
verse events
[N]
Partic-
ipants dis-
contin-
uing study
due to ad-
verse events
[%]
Rehospital-
isation [N]
Rehospital-
isation [%]
Out-pa-
tient treat-
ment [N]
Out-pa-
tient treat-
ment [%]
Barczynski
2010
I: total thy-
roidectomy
191 0 0 0 0 0 0
C1: Dunhill
procedure
189 0 0 0 0 0 0
C2: bilateral
subtotal thy-
roidectomy
190 0 0 0 0 0 0
all: 570 0 0 0 0 0 0
Giles
2004
I: (near) to-
tal thy-
roidectomy
109 0 0 0 0 0 0
C:
subtotal thy-
roidectomy
109 0 0 4 3.7 0 0
all: 218 0 0 4 3.7 0 0
Pappalardo
1998
I: total thy-
roidectomy
69 0 0 0 0 0
C:
subtotal thy-
roidectomy
72 0 0 0 0 0 0
all: 141 0 0 0 0 0 0
Yang
2009
I: (near) to-
tal thy-
roidectomy
165 6 3.6 0 0 0 0
C:
subtotal thy-
roidectomy
181 2 1.1 2 1.1 0 0
all: 346 8 2.3 2 0.6 0 0
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“-” denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention
Appendix 10. Adverse events (III)
Intervention(s)
and comparator
(s)
Participants in-
cluded in analy-
sis
[N]
Permanent
recurrent laryn-
geal nerve palsy
[N] (%)
Transient
recurrent laryn-
geal nerve palsy
[N] (%)
Permanent hy-
poparathy-
roidism
[N] (%)
Transient
hypoparathy-
roidism
[N] (%)
Barczynski
2010
I: total
thyroidectomy
191 4 (2.1) 21 (11) 1 (0.5) 21 (11)
C1:Dunhill pro-
cedure
189 3 (1.6) 16 (8.5) 0 (0) 8 (4.2)
C2:
bilateral subtotal
thyroidectomy
190 2 (1.1) 8 (4.2) 0 (0) 4 (2.1)
all: 570 9 (1.6) 45 (7.9) 1 (0.2) 33 (5.8)
Giles
2004
I: (near) total
thyroidectomy
109 0 (0) 1 (0.9) 0 (0) 2 (1.8)
C: subtotal thy-
roidectomy
109 0 (0) 1 (0.9) 0 (0) 1 (0.9)
all: 218 0 (0) 2 (0.9) 0 (0) 3 (1.4)
Pappalardo
1998
I: total
thyroidectomy
69 0 (0) 2 (2.9) 2 (2.9) 24 (34.8)
C: subtotal thy-
roidectomy
72 1 (1.4) 2 (2.8) 1 (1.4) 13 (18.1)
all: 141 1(1.4) 4 (2.8) 3 (2.1) 37 (26.2)
Yang 2009 I: (near) total
thyroidectomy
165 0 (0) 3 (1.9) 0 (0) 11 (6.9)
C: subtotal thy-
roidectomy
181 0 (0) 3 (1.7) 0 (0) 9 (5)
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all: 346 0 (0) 6 (1.8) 0 (0) 20 (5.9)
“-” denotes not reported
Dunhill procedure: unilateral extracapsular total thyroidectomy and contralateral subtotal thyroid lobe resection
C: comparator; I: intervention
Appendix 11. Survey of authors providing information on included trials
Study author contacted Study author replied Study author asked for ad-
ditional information
Study author provided
data
Barczynski 2010 Yes Yes Yes Yes
Giles 2004 Yes No N/A N/A
Pappalardo 1998 Yes Yes Yes No
Yang 2009 Yes No N/A N/A
N/A: not applicable
C O N T R I B U T I O N S O F A U T H O R S
Roberto Cirocchi (RC) protocol draft, search strategy development, trial selection, acquiring trial reports, data extraction, data analysis,
data interpretation, write discussion/author conclusion and future update draft.
Stefano Trastulli (STr): protocol draft, quality trials analysis and risk of bias.
Justus Randolph (JR): statistical consultation, data analysis, data interpretation and future update of draft.
Salvatore Guarino (SG): protocol draft and write the discussion.
Giorgio Di Rocco (GDR): trial selection, acquiring trial reports, data extraction, data analysis.
Alberto Arezzo (AR): trial selection, acquiring trial reports, data extraction, data analysis, data interpretation, write discussion/author
conclusion and future update draft.
Vito D’Andrea (VDA): revised draft.
Alberto Santoro (AS): revised draft.
Marcin Barczyñski (MB): protocol draft, write the discussion/author conclusion, revised draft and future update draft.
Nicola Avenia (NA): protocol draft, acquiring trial reports. write the discussion/author conclusion, revised draft and future update draft
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D E C L A R A T I O N S O F I N T E R E S T
RC: none known.
STr: none known.
JR: none known.
SG: none known.
GDR: none known.
AR: none known.
VDA: none known.
AS: none known.
ARe: none known.
MB: was the principal investigator of Barczynski 2010. MB did not extract data from his own study. The Coordinating Editor of the
CMED Group extracted these data, and checked the interpretation against the study registration details (NCT00946894).
NA: none known.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
None
N O T E S
We have based parts of the background, the methods section, appendices, additional tables and figures 1 to 3 of this review on a standard
template established by the CMED Group.
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